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Abstract
Purpose: In ADPKD patients total kidney volume
(TKV) measurement using MRI is performed to predict
rate of disease progression. Historically T1 weighted
images (T1) were used, but the methodology of T2
weighted imaging (T2) has evolved. We compared the
performance of both sequences.
Methods: 40 ADPKD patients underwent an abdominal
MRI at baseline and follow-up. TKV was measured by
manual tracing with Analyze Direct 11.0 software. Three
readers established intra- and interreader coefficients of
variation (CV). T1 and T2 measured kidney volumes and
growth rates were compared with ICC and Bland–
Altman analyses.
Results: Participants were 49.7 ± 7.0 years of age, 55.0%
female, with estimated GFR of 50.1 ± 11.5 mL/min/
1.73 m2. CVs were low and comparable for T2 and T1
(intrareader: 0.83% [0.48–1.79] vs. 1.15% [0.34–1.77],
P = 0.9, interreader: 2.18% [1.59–2.61] vs. 1.69%
[1.07–3.87], P = 0.9). TKV was clinically similar, but
statistically significantly different between T2 and T1:
1867 [1172–2721] vs. 1932 [1180–2551] mL, respectively
(P = 0.006), with a bias of only 0.8% and high agree-
ment (ICC 0.997). Percentage kidney growth during
2.2 ± 0.3 years was similar for T2 and T1 (9.3 ± 10.6%
vs. 7.8 ± 9.9%, P = 0.1, respectively), with a bias of
1.5% and high agreement (ICC 0.843). T2 was more
often of sufficient quality for volume measurement
(86.7% vs. 71.1%, P < 0.001).
Conclusions: In patients with ADPKD, measurement of
kidney volume and growth rate performs similarly when
using T2 compared to T1 weighted images, although T2
performs better on secondary outcome parameters; they
are more often of sufficient quality for volume measure-
ment and result in slightly lower intra- and interreader
variability.
Key words: T1—T2—MRI—ADPKD—Polycystic
kidney disease—Total kidney volume
Autosomal Dominant Polycystic Kidney Disease
(ADPKD) is the most common hereditary renal disease,
with a prevalence of 3–4 per 10,000 in the general pop-
ulation [1, 2]. The disease is characterized by cyst for-
mation in both kidneys, leading to pain, hematuria, and
renal function loss. Seventy percent of the affected pa-
tients reach end-stage renal disease between the fourth
and seventh decade of life [3].
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Monitoring glomerular ﬁltration rate to assess disease
severity and progression in ADPKD has limitations,
because GFR can remain within the normal range for
prolonged periods of time, despite nephron loss, due to
hyperﬁltration of residual nephrons [4]. Measurement of
total kidney volume (TKV) has been shown to be a
reliable surrogate for assessment of disease severity and
progression in these patients, with MR imaging being
superior to ultrasonography, particularly for the visual-
ization of small renal cysts [5, 6].
Historically, gadolinium enhanced T1 weighted ima-
ges were used for the measurement of TKV because of
the short scanning time, low variations in image quality
and high contrast of the renal structures against the
surrounding tissues [7]. In patients with impaired kidney
function the use of gadolinium is avoided, because
exposure to this contrast agent has been found to be
associated with a higher incidence of nephrogenic sys-
temic fibrosis [8], although the risk for this complication
is probably lower than previously assumed [9]. When not
using gadolinium contrast, T2 weighted images might be
preferred over T1 weighted images for the measurement
of the TKV, because this technique shows high kidney
tissue contrast and hyperintense renal cysts, that may
help to better delineate the kidney boundaries against
background tissue [5]. In the past, T2 weighted imaging
required longer scanning time and multiple breath-hold
scanning, and was more prone to misregistration, motion
artifacts and heterogeneous tissue signal intensities
leading to high variation in scanning quality [7]. For that
reason non-gadolinium-enhanced T1-MR imaging has
become the preferred method to assess TKV. However,
the single-shot T2 weighted techniques have evolved over
the last decades, making T2 weighted imaging potentially
preferable over T1 weighted imaging for TKV measure-
ment. For instance, the single-shot fast spin-echo T2
technique has a shorter examination time, fewer motion
artifacts, and the technique ensures that all images are
obtained from the same anatomic position regardless of
the patients’ ability to hold their breath [10].
We compared the performance of using T2 and T1
weighted MR images for the measurement of kidney
volume and growth in patients with ADPKD, and tested
the hypothesis that the use of T2 might be preferred over
T1 weighted images.
Materials and methods
Patients and study design
For this study MR images were used of a subset of
ADPKD patients that participated in the DIPAK-1
study, a randomized controlled trial in which the efﬁcacy
of lanreotide to halt disease progression in ADPKD is
assessed. Patients diagnosed with ADPKD based on the
revised Ravine criteria [11], aged 18–60 years, with an
estimated glomerular filtration rate (eGFR) of
30–60 mL/min/1.73 m2 were included between 2012 and
2015 at the University Medical Centers of Groningen
(UMCG), Leiden (LUMC), Nijmegen (Radboud UMC)
and Rotterdam (Erasmus MC), all in the Netherlands.
Details of the study protocol have been published else-
where [12]. The Medical Ethical Committee of the UMC
Groningen approved the protocol of this study that was
conducted in accordance with the International Confer-
ence of Harmonization Good Clinical Practice Guideli-
nes and in adherence to the ethical principles that have
their origin in the Declaration of Helsinki. Informed
consent was obtained from all individual participants
included in the study.
Magnetic resonance imaging
All participants underwent a standardized abdominal
MRI without the use of intravenous contrast. All MR
images were made using a 1.5 or 3.0 Tesla MRI scanner.
Five different MRI scanners were used: (1) Magnetom
Avanto, Siemens, Erlangen, Germany; (2) Ingenia,
Philips, Eindhoven, the Netherlands; (3) GE Medical
Systems, Buckinghamshire, United Kingdom; (4) In-
tera, Philips, Eindhoven, the Netherlands; and (5)
Magnetom TRIO, Siemens, Erlangen, Germany. Coils
were placed onto the anterior and posterior abdominal
walls directly over the kidneys. A short scout was
scanned to localize the kidneys. Subsequently two series
of images were scanned for these analyses. First a
coronal T2 single-shot fast spin echo was scanned (slice
thickness 4 mm, gap/spacing 0 mm, FOV 35 cm, matrix
256 9 256, ﬂip angle = 40–50, and different TR’s
and TE’s (always in-phase) per brand MRI scanner:
TE  100 ms for Siemens, TE  190 ms and
TR  max. 1400 ms for GE and TE  70 ms and
TR  max. 1900 ms for Philips). Thereafter a coronal
T1-3D spoiled gradient echo was made (same charac-
teristics except TE  2 ms, TR  4 ms and ﬂip angle
£15). When a 35 cm FOV was insufﬁcient, the FOV
could be increased. The ﬁrst and the last slice of the scan
had to be an image without kidney tissue, to ensure
whole organ imaging. The obtained MR images were
anonymized and sent via a secured server to the central
reading facility at the UMC Groningen, where kidney
volumes were measured. The three readers were specif-
ically trained to measure TKV on both T1 as well as T2
weighted images. During their training period, they
measured 15 MR images per sequence, thus 30 kidney
volumes, under supervision and guidance of an experi-
enced MRI technician using a standard operating pro-
cedure. After these readers completed their training,
they were allowed to measure TKV. This protocol was
implemented in 2012 and was not changed during the
study to avoid systematic bias.
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Measuring kidney volume on T1 and T2 weighted
images
Kidney volumes were measured on the coronal T2 single-
shot fast spin-echo sequence and the coronal T1-3D
spoiled gradient echo (Fig. 1). If one of those sequences
showed too low quality, the patient was not eligible for
these analyses. The assessment of quality was based upon
the judgment of one reader whether or not the kidney
boundaries were manually traceable. This was predomi-
nantly based on the appearance of motion artifacts.
When the quality of the image was deemed too low,
another reader was asked to confirm this assessment. The
kidney boundaries were manually traced using the
commercially available software Analyze Direct 11.0
(Analyze Direct, Inc., Overland Park, KS, USA). The
kidney volumes were calculated from the set of con-
tiguous images by summing the products of the area
measurements within the kidney boundaries and slice
thickness. Non-renal parenchyma, e.g., the renal hilus,
was excluded from measurement. Importantly, all mea-
surements were performed by readers blinded for patient
number and previous TKV measurements.
Statistical analysis
Baseline characteristics of the study population are gi-
ven. Data are provided as mean with standard deviation
(SD), or as median with interquartile range [IQR] in case
of non-normal distribution.
In a test set of 12 patients kidney volumes were
measured twice by three readers. This test set was used to
assess the intra- and interreader reliability. Three MR
images per MRI scanner were selected. Kidney volumes
ranged from approximately 670 to 4000 mL. The intra-
and interreader reliability for the left, right, and total
kidney volume were assessed using the intraclass corre-
lation coefﬁcient (ICC). Reproducibility was evaluated
by assessing intra- and interreader coefﬁcient of vari-
ability (CV). Intrareader CV was calculated per MR
image for each of the readers as the standard deviation of
the two TKV values divided by the mean TKV multiplied
by 100%. Interreader CV was calculated for each of the
12 MR images as the standard deviation of TKV values
assessed by all three readers divided by the mean TKV of
that image multiplied by 100%. As subgroup analysis
intra- and interreader CVs were calculated for the dif-
Fig. 1. Examples of the
T1-3D spoiled gradient echo
(left) and T2 single-shot fast
spin echo (right), examples
from two different patients
on two different scanners.
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ferent MRI scanners separately and for quartiles of T1
breath-hold trigger time.
To investigate whether the TKV results obtained with
T1 and T2 weighted images correlate, orthogonal
regression analysis was performed, and the ICC was
calculated using all MR images of our cohort. Agree-
ment between T1 and T2 measurements was evaluated by
Bland–Altman analyses, where bias and precision are
deﬁned as mean difference and SD of the mean differ-
ence. Subsequently, serial MR images of 40 patients were
used to determine whether both methods can accurately
detect changes in TKV. Correlation between changes in
TKV measured using T1 and T2 weighted images was
assessed similarly using orthogonal regression analysis,
calculation of ICC, and Bland–Altman analyses. Follow-
up scans were preferably performed on the same MRI
scanner as at baseline, and TKV was measured using the
same series of images as at baseline. As sensitivity anal-
yses we tested whether differences in kidney volumes
(cross-sectionally) and growth rate (longitudinally) be-
tween T1 and T2 were dependent on the type of MRI
scanner, T1 breath-hold trigger time, or on height-ad-
justed total liver volume, according to the polycystic liver
disease (PLD) classiﬁcation [13].
To assess the consequences of using T2 instead of T1
weighted images, four analyses were performed. First,
the effect on classiﬁcation according to Mayo height-
adjusted TKV (htTKV) risk class [14], and second, the
consequences for the sample size calculation of clinical
trials were assessed (assuming a power of 80% and a
2-sided a of 0.05). Third, we analyzed the percentage of
MR images that was deemed sufficient for TKV mea-
surement. Fourth, we compared the duration of TKV
measurement using T2 and T1 weighted images.
Differences in paired non-parametric data were tested
with a Wilcoxon signed-rank test and in paired para-
metric data with a paired T test. A one sample T test was
used when analyzing percentage difference of volumes
measured on T2 compared to T1 weighted images, taking
the volumes on T1 weighted images as 100%. For testing
between more than two groups, a Kruskal–Wallis test
was used for non-parametric data and an ANOVA for
parametric data with Bonferroni correction. A v2 test
was used for differences between proportions. All anal-
yses were performed with SPSS, version 22.0 (SPSS Inc).
P < 0.05 was considered to be statistically significant.
Results
Patient characteristics
Of the 40 included patients, 55.0% was female and the
average age was 49.7 ± 7.0 years. Estimated GFR was
50.1 ± 11.5 mL/min/1.73 m2. The mean systolic and
diastolic blood pressure values were 135 ± 13 and
83 ± 9 mmHg, respectively. Of all patients 97.5% used
antihypertensive medication of which 87.5% used a
RAAS blocker. Patients had a follow-up of
2.2 ± 0.3 years.
Intra- and interreader reliability
The intra- and interreader reliability for both the T1 and
T2 weighted images were high, with ICCs ranging from
0.997 to 1.000. Although the intra- and interreader CVs
Table 1. Intra- and interreader coefficients of variability in kidney volume measurements when using T1 or T2 weighted images (three readers)
Intrareader CV (%) Interreader CV (%)
T1 T2 T1 T2
Left kidney 0.94 [0.52–1.65] 0.62 [0.25–0.87]* 1.62 [1.12–3.57] 1.00 [0.89–1.52]*
Right kidney 1.46 [0.71–2.00] 0.63 [0.25–1.04]* 2.63 [0.88–4.10] 1.25 [0.80–1.88]*
Total kidney 1.15 [0.34–1.77] 0.83 [0.48–1.79] 1.69 [1.07–3.87] 2.18 [1.59–2.61]
Values are given as median [IQR]. P values were calculated using a paired Wilcoxon signed-rank test
CV coefficient of variability
*P < 0.05
Table 2. Differences in kidney volume, when measured using T1 or T2 weighted images
Volumes (mL) Differences in volume (mL)
[T1–T2]
Differences in volume (%)
[(T1 - T2)/average T1|T2 9 100]
T1 T2 Bias Precision P value Bias Precision P value
Left kidney 1015 [657–1260] 1012 [648–1333] -7.2 81.4 0.6 -0.2 5.7 0.7
Right kidney 846 [512–1188] 874 [513–1246] -24.0 63.4 <0.001 -1.5 7.0 0.06
Total kidney 1932 [1180–2551] 1867 [1172–2721] -31.2 119.2 0.006 -0.8 5.1 0.2
Values are given as median [IQR]. P values are calculated using a paired Wilcoxon signed-rank test for absolute differences; for percentage
differences a one sample T test was used
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of both T1 and T2 weighted images were comparable for
TKV, the intra- and interreader CVs for the separate
kidneys were signiﬁcantly lower for T2 (Table 1). There
were no significant differences in intra- and interreader
CVs between the right and left kidney, neither for T1
(P = 0.1 and P = 0.5, respectively) nor for T2 (P = 0.5
and P = 0.8, respectively) weighted images. No signifi-
cant differences in intra- or interreader CVs were ob-
served between the different MRI scanners or according
to T1 breath-hold trigger time for the left, right, or total
kidney volume (Supplementary Tables 1 and 6).
Comparing T1 and T2 weighted images
to measure kidney volume
The volumes measured on T1 weighted images were
clinically similar, but statistically signiﬁcantly different
from the volumes measured on T2 weighted images; 1932
[1189–2551] mL vs. 1867 [1172–2721] mL, P = 0.006
(Table 2). Volumes measured using T2 and T1 weighted
images showed a high correlation with an ICC of 0.997,
without indication for systemic bias in the lower or
higher TKV range when T2 weighted images were used
instead of T1 weighted images, with a bias and precision
of -0.8 and 5.1% (Fig. 2). When the various MRI
scanners were studied separately, in general similar re-
sults were obtained (Supplementary Table 2). When the
included subjects were stratified according to polycystic
liver volume subclass or according to T1 breath-hold
trigger time, again essentially similar results were ob-
tained (Supplementary Tables 3 and 7).
Comparing T1 and T2 weighted images to detect
changes in kidney volume
The percentage change in TKV during follow-up was
not different when comparing T1 to T2 weighted images
(7.8 ± 9.9% vs. 9.3 ± 10.6%, respectively, P = 0.1,
Table 3), and showed a high correlation (ICC 0.843,
P < 0.001), without systematic under- or overestima-
tion, with a bias and precision of -1.5 and 5.6% (Fig. 3).
The results for the various individual MRI scanners were
essentially similar to these overall results (Supplementary
Table 4).
Consequences of using T2 instead of T1 weighted
images
We analyzed the consequences of using T2 instead of T1
weighted images for risk assessment according to the
Fig. 2. Cross-sectional
associations of TKV
measured using T1 or T2
weighted MR images. Left
panel shows scatter plot,
with solid line representing
the line of identity, and
dotted line the actual
regression line. The right
panel shows a Bland–
Altman plot, with solid line
representing no difference,
and dotted line the actual
mean difference (bias) with
95% confidence interval.
Fig. 3. Associations of
change in TKV when
measured using T1 or T2
weighted MR images. Left
panel shows scatter plot,
with solid line representing
the line of identity, and
dotted line the actual
regression line. The right
panel shows a Bland–
Altman plot, with solid line
representing no difference,
and dotted line the actual
mean difference (bias) with
95% confidence interval.
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Mayo classiﬁcation, that categorizes patients into ﬁve
risk classes for disease progression based on htTKV at a
given age [14]. Thirty-four out of the forty patients (85%)
remained in their original risk class, whereas two patients
(5%) were reclassified to a higher and four patients (10%)
to a lower risk category. In addition, we analyzed the
consequences for the number of subjects to be included
in a clinical trial when change in TKV would be the
endpoint, and when this change in TKV was to be
measured with T2 instead of T1 weighted images. Power
analyses indicated that a somewhat smaller patient group
has to be randomized when measuring TKV on T2
weighted images (Table 4).
Of all baseline MR images of the DIPAK-1 study
participants (n = 308), the percentage of T1 and of T2
weighted images that was deemed suitable for TKV
measurement was 71.1% and 86.7%, respectively
(P < 0.001). The remaining MR images were not suit-
able for volume measurement, because the quality of the
images was insufficient. Sensitivity analysis showed that
the results were not different across the various MRI
scanners (Supplementary Table 5). The time needed to
assess TKV was on average 41.6 ± 13.0 min for a T1
weighted scan and 44.8 ± 16.4 min for a T2 weighted
scan (P = 0.09).
Discussion
TKV is an increasingly important biomarker for the
assessment of disease severity and disease progression in
patients with ADPKD and has recently been accepted by
the FDA and the European Medicines Agency as a
prognostic biomarker to select patients with ADPKD for
clinical trials. The T2 weighted imaging technique has
been suggested to be more reliable for kidney volume
measurement in ADPKD compared to T1 weighted
images without gadolinium [7]. However, to our knowl-
edge, no studies have been performed to investigate
possible differences in TKV measurement between these
two MRI techniques.
Signal differences between kidney and surrounding
tissues have previously been shown to be important in
TKV measurement in ADPKD, as Bae et al. found that
T1 weighted images without gadolinium resulted in sig-
niﬁcantly smaller kidney volumes [7]. In the present
study TKV could be assessed as reliable and reproducible
using T2 weighted images instead of T1 weighted images,
although slightly lower intra- and interreader variability
was observed for T2 weighted images. Volume and
growth rate assessed on T1 and T2 weighted images
showed very high correlations. The assessment time for
TKV was equal for both techniques, whereas the per-
centage of approved scans, based on the quality of
images, was higher for T2 compared to T1 weighted
images.
In T1 weighted images tissues with high fat content
appear hyperintense (e.g., perinephric fat) and com-
partments ﬁlled with water (e.g., cysts) appear hy-
pointense, whereas the opposite is true for T2 weighted
images. As a consequence T2 weighted images have a
higher soft-tissue contrast and hyperintense renal cysts
that help to delineate the kidney boundaries against
background tissue more easily [7]. Of note, the soft-tissue
contrast is dependent on whether or not fat suppression
is used. In our cohort we included MR images with and
without fat suppression, which was dependent on the
type of scanner used. This could theoretically lead to
volume differences between T1 and T2 weighted images.
Table 3. Changes in kidney volumes when measured using T1 or T2 weighted images
T1 T2 P value
Left kidney
Baseline volume (mL) 971 [641–1172] 976 [591–1218] 0.9
Follow-up volume (mL) 1049 [657–1351] 1062 [654–1416] 0.3
Change (mL) 74.3 ± 131.3 92.5 ± 132.1 0.08
Change (%) 7.1 ± 11.2 8.0 ± 13.3 0.4
Right kidney
Baseline volume (mL) 789 [526–1051] 784 [503–1136] 0.06
Follow-up volume (mL) 881 [503–1206] 896 [542–1284] <0.001
Change (mL) 91.7 ± 131.6 111.4 ± 140.5 0.04
Change (%) 9.0 ± 11.6 11.1 ± 9.9 0.1
Total kidney
Baseline volume (mL) 1800 [1180–2411] 1810 [1127–2621] 0.3
Follow-up volume (mL) 2055 [1166–2646] 2017 [1172–2943] 0.006
Change (mL) 166.1 ± 211.8 203.9 ± 236.4 0.02
Change (%) 7.8 ± 9.9 9.3 ± 10.6 0.1
Values are given as mean ± SD or median [IQR]. P values were calculated using a paired Wilcoxon signed-rank test in case of non-parametric data,
in case of parametric data a paired T test was used
Table 4. Sample size calculation for clinical trials using T1 or T2
weighted images adopting a power of 80% and a two-sided alpha of
0.05




M. D. A. van Gastel et al.: T1 vs. T2 weighted magnetic resonance imaging
However, a sensitivity analysis showed similar results for
the comparison of T1 vs. T2 across the various scanners
that were used, which indicates that there is no major
effect of fat suppression on differences in volumes be-
tween T1 and T2 weighted images. The breath-hold
trigger time was less than 26 s for all T1 weighted MR
images and also caused no differences in volumes mea-
sured on T1 and T2. Another factor that influences the
quality of MR images is related to the content of cysts.
Hemorrhagic cysts appear hyperintense compared to the
surrounding cysts on T1 weighted images, whereas they
are hypointense on T2 weighted images and possibly
more difficult to recognize on this sequence. Hemor-
rhagic cysts that occur at the border of the kidney can be
missed, which theoretically could affect the measured
TKV on T2 weighted images. However, we did not
encounter this when reviewing differences in TKV values
between T1 and T2 weighted images. Lastly, although
the aforementioned factors could cause differences in
TKV when measured using T1 or T2 weighted images,
we hypothesize that kidney volumes are probably that
large in patients with ADPKD, that the aforementioned
factors have no relevant effect.
We found however, that T1 weighted images resulted
in statistically signiﬁcant smaller kidney volumes.
Nonetheless, volumes were clinically similar with a mean
difference between volumes of less than one percent,
which is less than the interreader CV and therefore of
low clinical relevance. This assumption was conﬁrmed
when assessing the consequences for risk classiﬁcation
using the Mayo htTKV classiﬁcation; only 15% of pa-
tients was reclassiﬁed using the kidney volumes observed
on T1 vs. T2 measurements. In addition, no systemic
over- or under-classiﬁcation was observed. When look-
ing in detail at the differences in TKV assessed on T1 vs.
T2 weighted images, we found that the smaller T1 TKV
was driven by the right kidney volume. This led us to
hypothesize that the liver might have caused difﬁculties
in distinguishing kidney from liver tissue. To corroborate
our hypothesis, we therefore performed a sensitivity
analysis according to the PLD classiﬁcation [13]. How-
ever, we found no significant difference between the
different liver volumes, but this analysis is hampered by
the fact that we had only four patients in the most severe
polycystic liver category.
The performance of T1 and T2 weighted images in
assessing percentage kidney growth was similar. How-
ever, when calculating the number of patients needed for
clinical trials that test novel renoprotective agents and
change in TKV as endpoint, fewer patients were needed
when using T2 instead of T1 weighted images. Moreover,
when analyzing the percentage of T1 and T2 weighted
MR images that were deemed suitable for volume mea-
surement, we found that T1 weighted images were more
often rejected because the quality of the images was
insufﬁcient to reliably delineate the kidney borders for
volume measurement. In clinical practice this would re-
sult in making an extra MRI, with an increase in costs
and patient burden as a result. This could form a ratio-
nale to only scan T2 weighted images for the assessment
of kidney volume, which would save scanning time.
Lastly, although TKV growth rates were similar when
using T1 or T2 weighted images, one should consider
using the same sequence for follow-up within one pa-
tient, to reduce measurement variations introduced using
two different sequences in one patient.
Our study has the limitation that it was performed in
a relatively small number of patients. However, this
number of patients has previously shown to be sufﬁcient
to detect differences in total kidney volume measurement
techniques in ADPKD [7]. Second, the MR images were
made in patients participating in a randomized con-
trolled trial with specific inclusion criteria for age and
renal function to enrich the patient population for a high
likelihood of rapid disease progression. This may limit
extrapolation of our findings to the general ADPKD
population.
Strengths of our study are that we had follow-up data
available, enabling us to compare change in TKV, which
is one of the most important parameters for disease
progression in patients with ADPKD. In addition, we
had three readers measuring TKV to assess intra- and
interreader variability, and multiple parameters were
available to assess feasibility of the two techniques, such
as duration of assessment and approval rates of T1 and
T2 weighted images.
In conclusion, we found that kidney volumes and
kidney volume growth rates assessed on T2 and T1
weighted images were comparable. These ﬁndings show
that T2 weighted images can be used, but are not supe-
rior to T1 weighted images for kidney volume measure-
ment in patients with ADPKD. Differences between T2
and T1 were small, and likely not clinically relevant al-
though on secondary outcome parameters T2 had minor
advantages over T1 weighted images.
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